BioTech 365

DECEMBER 6, 2021

NOXXON Announces Enrolment of First Patient in the Expansion of the NOX-A12 Phase 1/2 Trial in Brain Cancer NOXXON Announces Enrolment of First Patient in the Expansion of the NOX-A12 Phase 1/2 Trial in Brain Cancer BERLIN–(BUSINESS WIRE)–Regulatory News: NOXXON … Continue reading →

Trials 40

Trials 40

BioTech 365

NOVEMBER 3, 2021

NOXXON Provides Update on Timing for Upcoming Trials of NOX-A12 in Pancreatic and Brain Cancer NOXXON Provides Update on Timing for Upcoming Trials of NOX-A12 in Pancreatic and Brain Cancer BERLIN–(BUSINESS WIRE)–Regulatory News: NOXXON Pharma N.V.

Trials 40

Trials 40

Drug Discovery World

SEPTEMBER 9, 2022

News round-up for 5-9 September by DDW Digital Content Editor Diana Spencer. Cancer research has been making headlines over the last seven days in the build-up to the European Society for Medical Oncology (ESMO) Congress 2022. This week’s top stories: Combination therapy halts lung cancer tumour growth in mice.

Drugs 52

Drugs Genetic Engineering Genetics Engineer 52

Drug Discovery World

DECEMBER 8, 2023

News round-up for 4-8 December by DDW Digital Content Editor Diana Spencer. DNA therapy effective against chemo-resistant ovarian cancer A novel DNA vaccine in combination with chemotherapy has demonstrated promising clinical results against a deadly form of ovarian cancer.

Drugs 52

Drugs DNA Clinical Trials Clinical Trials 52

BioTech 365

MAY 31, 2021

NOXXON Announces Positive Results From Second Cohort in Phase 1/2 NOX-A12 Brain Cancer Trial NOXXON Announces Positive Results From Second Cohort in Phase 1/2 NOX-A12 Brain Cancer Trial BERLIN, Germany–(BUSINESS WIRE)–Regulatory News: NOXXON Pharma N.V.

Trials 52

Trials 52

BioTech 365

MAY 10, 2021

NOXXON Announces Data Safety Monitoring Board Validates NOX-A12 Highest Dose in Phase 1/2 Brain Cancer Trial NOXXON Announces Data Safety Monitoring Board Validates NOX-A12 Highest Dose in Phase 1/2 Brain Cancer Trial BERLIN–(BUSINESS WIRE)–Regulatory News: NOXXON Pharma N.V.

Trials 40

Trials 40

Drug Discovery World

FEBRUARY 28, 2024

Lu Rahman selects some of the year’s interesting and noteworthy advances in cancer research drug discovery and development. As always, a year within cancer drug discovery and development brings with it significant breakthroughs, and 2023 has been no exception. Figures from the Amercian Cancer Society 1 state that “a little over 1.9

Development 64

Development Research Drugs Antibody 64

XTalks

APRIL 19, 2024

CINA-ASPECTS assists in the assessment of stroke severity by automatically processing non-contrast CT scans to calculate the ASPECT score — a method used to quantify brain damage severity following a stroke. The tool can be particularly useful in conditions like cancer where pulmonary embolism is a significant cause of mortality.

Marketing 52

Marketing Radiology Development Manufacturing 52

Delveinsight

SEPTEMBER 9, 2021

A collaboration valued more than USD 3 billion, Genentech, a member of the Roche Group, declared it will collaborate with Adaptimmune for developing and commercializing allogeneic T-cell therapies to treat multiple cancer indications. A portion of the new funding will also be utilized to improve the Breath Biopsy platform.

FDA Approval 73

FDA Approval Development Research Production 73

BioTech 365

APRIL 22, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: XYZeq: A better map of cell diversity.Not all cancer cells within a tumor are created equal; nor do all immune cells (or all liver or brain cells) … Continue reading →

Research 40

Research 40

Drug Discovery World

FEBRUARY 23, 2024

The US Food and Drug Administration (FDA) has approved AstraZeneca’s osimertinib (Tagrisso) as a treatment for locally advanced or metastatic non-small cell lung cancer (la/mNSCLC). This news is especially important for those with a poorer prognosis, including patients whose cancer has spread to the brain and those with L858R mutations.”

Trials 52

Trials Drugs 52

The Pharma Data

JANUARY 12, 2021

12, 2021 — A foodborne pathogen may be linked to a type of rare brain cancer in adults, a new study suggests. Researchers found that people who have glioma are more likely to have antibodies to toxoplasma gondii than a similar group that was cancer-free. ” Glioma is a relatively rare, but often fatal, cancer.

Antibody 52

Antibody Research Development 52

Drug Discovery World

APRIL 28, 2023

News round-up for 24-28 April by DDW Digital Content Editor Diana Spencer. The stories cover the efforts by research teams to discover innovative novel drugs for geographic atrophy, HIV, lung cancer, anxiety and diabetes.

Drugs 52

Drugs Life Science Clinical Trials Clinical Trials 52

World of DTC Marketing

JUNE 5, 2021

Obesity and Cancer. Being overweight or having obesity are linked with a higher risk of getting 13 types of cancer. These cancers make up 40% of all cancers diagnosed in the United States each year. Being overweight and having obesity are linked with a higher risk of getting 13 kinds of cancer. Multiple myeloma.

Medicine 193

Medicine Gene Genetics Research 193

Drug Discovery World

DECEMBER 12, 2022

DDW highlights the most interesting global news and comments within the drug discovery and development sector this month. . Everyone enjoys a good news story and the drug discovery and development sector is no exception. In Nature 3 , we learnt about the CRISPR cancer trial success leading the way to personalised treatments.

Drugs 52

Drugs Gene Editing Genome Genomics 52

Worldwide Clinical Trials

FEBRUARY 28, 2023

He found out he had brain cancer — a rare, aggressive brain cancer with only a 15% chance of living even another five years. “To Though cancer ran in my family, we definitely weren’t expecting this news, and the survival rates left little to be hopeful for,” says Rob. By all appearances, I was healthy.

Clinical Trials 130

Clinical Trials Clinical Trials Research Trials 130

Triage Cancer

AUGUST 17, 2021

National News. State News (Missouri, California, Connecticut, Pennsylvania, Louisiana, Texas). About Triage Cancer. Here is the latest news about laws and programs at both the national and state levels that may be relevant to you. National News. State News. About Triage Cancer. Table of Contents.

Doctors 52

Doctors Doctor Genetics 52

XTalks

APRIL 11, 2022

The drugs have also been shown to have anti-cancer and neuroprotective effects. Related: Parkinson’s and Melanoma Share an Amyloid Link, Says New Research. If statins can decrease the risk of people developing parkinsonism movement disorders, that could be good news for the 60,000 people who develop them,” said Dr. Oveisgharan.

Development 98

Development Containment Research Drugs 98

Drug Discovery World

NOVEMBER 1, 2023

Many drug discovery companies took the opportunity to share their latest cancer research findings. Amivantamab, Janssen Data from the Phase III MARIPOSA study showed amivantamab plus lazertinib improved PFS by 30% compared to osimertinib in patients with first-line advanced EGFR-mutated non-small cell lung cancer (NSCLC).

Clinical Trials 59

Clinical Trials Clinical Trials Trials HR 59

pharmaphorum

DECEMBER 24, 2020

Bristol Myers-Squibb has put out another downbeat “update” announcement about its immunotherapy Opdivo in an aggressive form of brain cancer, saying that it looks unlikely to produce a survival benefit in the disease. The post BMS calls time on brain cancer trial as Opdivo misses second target appeared first on.

Trials 52

Trials Doctors Doctor Drugs 52

XTalks

JUNE 30, 2023

“The approval of Ultravist-300 and -370 in contrast-enhanced mammography gives physicians a new imaging option where conventional mammography might not be enough,” said Dr. Konstanze Diefenbach, head of Radiology Research and Development at Bayer, in the company’s news release. “We How Does Ultravist (iopromide) Work?

FDA Approval 98

FDA Approval Radiology Trials Life Science 98

pharmaphorum

JANUARY 19, 2021

The Scottish Medicines Consortium (SMC) has given a green light to Roche’s Rozlytrek for a rare form of lung cancer, almost seven months after NICE backed the drug in England. ROS1 is a rare mutation found in fewer than 2% of NSCLC cases, and patients have few treatment options, especially when the disease has spread to the brain.

Medicine 85

Medicine Gene Drugs Production 85

The Pharma Data

OCTOBER 22, 2020

22, 2020 — If Obamacare, or the Affordable Care Act (ACA), is repealed, pediatric cancer patients could lose critical insurance coverage, a new study warns. Kids with cancer often require intensive treatment and long-term follow-up to beat the disease. Most had leukemia, lymphoma or tumors of the brain or spine.

Research 52

Research 52

The Pharma Data

SEPTEMBER 14, 2020

. AstraZeneca’s Tagrisso (osimertinib) has been recommended for use within NHS England, in line with its licensed indication, for adults with untreated locally-advanced or metastatic epidermal growth factor receptor (EGFR) mutation-positive non-small cell lung cancer (NSCLC). in the UK. “Our Source link.

Medicine 52

Medicine Clinical Trials Clinical Trials Licensing 52

pharmaphorum

SEPTEMBER 12, 2020

UK cost-effectiveness watchdog NICE has changed its stance on AstraZeneca’s Tagrisso as a first-line therapy for non-small cell lung cancer (NSCLC) after an improved “commercial arrangement” with the company. NICE also delivered less positive news to two other drugmakers in its latest batch of guidance.

Sales 65

Sales Drugs Clinical Trials Clinical Trials 65

Triage Cancer

OCTOBER 7, 2021

Additionally, research shows that receiving bad news, such as a cancer diagnosis, can make it harder to process information and form memories. 100% of the profits from the sale of ZaggoCare are donated to pediatric brain tumor research in memory of Zachary. About Triage Cancer.

Doctors 52

Doctors Doctor Research Sales 52

Triage Cancer

OCTOBER 29, 2020

When the body feels unsafe — whether it’s a physical threat of attack or a psychological fear of losing a job or catching a disease — the brain signals adrenal glands to pump stress hormones. This leads to increased inflammation throughout the body and brain, and a poorly functioning immune system. Meditation and mindfulness.

Hormones 75

Hormones Doctors Doctor Pharmacy 75

Delveinsight

AUGUST 24, 2021

Unpleasant news strike hard for their first deal in the rare neurodegenerative disease domain. ” USFDA Grants Clinical Trial Approval to Beijing HebaBiz Biotech’s Siroquine (JP001) – An Innovative Anti-Cancer Drug. Siroquine is an innovative anti-cancer drug under development based on the Autophagy mechanism.

Clinical Trials 96

Clinical Trials Clinical Trials Trials Drugs 96

The Pharma Data

MAY 19, 2023

“Congratulations to the Regeneron International Science and Engineering Fair 2023 winners,” said Maya Ajmera, President and CEO, Society for Science and Executive Publisher, Science News. “I Detecting these cancers before they metastasize could make treatment much simpler and more effective.

Engineer 52

Engineer Scientist Protein Research 52

pharmaphorum

JUNE 7, 2021

Finding a therapy that treats the underlying cause of Alzheimer’s has proved elusive, with a long list of drugs targeting the amyloid brain plaques associated with the disease failing in the clinic. Breaking news: The FDA has approved Aducanumab, the first FDA-approved drug that delays decline due to Alzheimer’s.

FDA Approval 87

FDA Approval Drugs Trials Clinical Trials 87

Pharmaceutical Technology

JANUARY 30, 2023

The FDA approved fewer innovative drugs, New Molecular Entities (NMEs), in 2022 than it did in 2021: only 42 drugs compared to 59 drugs. The approval was based on claims that the drug led to a reduction in amyloid plaques in the brain. This is due to generally more stringent criteria on approvals in the wake of the Aduhelm scandal.

Drugs 130

Drugs Manufacturing Contract Manufacturing FDA Approval 130

The Pharma Data

AUGUST 10, 2020

Dating in 2020 is hard enough during a global pandemic – but how do you go about it if you’ve got cancer to contend with too? That’s despite 34 young adults – in their 20s and 30s – being diagnosed with cancer in the UK every day. “How do you tell someone ‘by the way, I had breast cancer at 25?'”

Doctors 52

Doctors Doctor 52

Delveinsight

FEBRUARY 2, 2021

The shares of Viela Bio skyrocketed more than 52% in premarket trading after the news was broadcasted. Thus, the news of its acquisition does not surprise as a horde of pharma giants would be keeping a keen eye on its activities. Horizon Therapeutics has announced to acquire Viela Bio for about $3.1

Drugs 40

Drugs Clinical Trials Clinical Trials Development 40

Delveinsight

DECEMBER 22, 2020

Servier Acquires Agios’ Cancer Portfolio in a USD 2 Billion Deal. After the news broke, shares of Agios soared in premarket trading. The post Agios’ cancer pipeline auction; uniQure’s gene therapy on hold; Ultragenyx, Mereo Deal; aTyr Pharma Trial appeared first on DelveInsight Business Research.

Gene Therapy 52

Gene Therapy Gene Trials Clinical Trials 52

XTalks

FEBRUARY 10, 2021

If left untreated, OSA can lead to serious long-term health consequences including heart attack, heart failure, glaucoma, diabetes, cancer and cognitive and behavioral disorders. OSA leads to significant sleep disruptions as the brain partially awakens in response to not breathing, forcing oneself to breath harder to get past the blockage.

Radiology 97

Radiology Marketing Clinical Trials Clinical Trials 97

The Pharma Data

JANUARY 7, 2021

Sanofi also expects to see fruits from the November 2020 acquisition of Kiadis Pharma and its cell-based immunotherapy for cancer. Looking ahead at the number of potential approvals and readouts in 2021, Berger predicted a substantial news flow from the company throughout the year. The BTK inhibitors gained in the $3.68

Protein 52

Protein Antibody Genetics Gene Therapy 52

The Pharma Data

OCTOBER 26, 2020

American Heart Association News. 26, 2020 (American Heart Association News) — Erin Wegener was a tiny baby facing enormous challenges. ” American Heart Association News covers heart and brain health. By Michael Merschel. MONDAY, Oct. Born at 29 weeks’ gestation, she weighed only 1 pound, 14 ounces.

Research 52

Research Doctors Doctor 52